Free Trial

SBC Medical Group (SBC) Competitors

SBC Medical Group logo
$3.06 -0.14 (-4.38%)
As of 03:36 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SBC vs. FTRE, TDOC, PNTG, CDNA, and OMDA

Should you buy SBC Medical Group stock or one of its competitors? MarketBeat compares SBC Medical Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SBC Medical Group include Fortrea (FTRE), Teladoc Health (TDOC), The Pennant Group (PNTG), CareDx (CDNA), and Omada Health (OMDA). These companies are all part of the "healthcare" industry.

How does SBC Medical Group compare to Fortrea?

SBC Medical Group (NASDAQ:SBC) and Fortrea (NASDAQ:FTRE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

SBC Medical Group presently has a consensus price target of $8.50, indicating a potential upside of 177.78%. Fortrea has a consensus price target of $17.25, indicating a potential upside of 10.86%. Given SBC Medical Group's higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Fortrea.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Fortrea
1 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.36

In the previous week, Fortrea had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 3 mentions for Fortrea and 1 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 0.93 equaled Fortrea'saverage media sentiment score.

Company Overall Sentiment
SBC Medical Group Positive
Fortrea Positive

60.8% of SBC Medical Group shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by insiders. Comparatively, 0.7% of Fortrea shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

SBC Medical Group has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market. Comparatively, Fortrea has a beta of 2.12, suggesting that its share price is 112% more volatile than the broader market.

SBC Medical Group has a net margin of 24.09% compared to Fortrea's net margin of -16.50%. SBC Medical Group's return on equity of 15.90% beat Fortrea's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group24.09% 15.90% 11.61%
Fortrea -16.50%9.51%1.96%

SBC Medical Group has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M1.81$50.99M$0.397.85
Fortrea$2.72B0.54-$986.20M-$4.91N/A

Summary

SBC Medical Group beats Fortrea on 10 of the 15 factors compared between the two stocks.

How does SBC Medical Group compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

In the previous week, Teladoc Health had 12 more articles in the media than SBC Medical Group. MarketBeat recorded 13 mentions for Teladoc Health and 1 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 0.93 beat Teladoc Health's score of 0.91 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company Overall Sentiment
Teladoc Health Positive
SBC Medical Group Positive

SBC Medical Group has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.53B0.50-$200.32M-$0.97N/A
SBC Medical Group$173.61M1.81$50.99M$0.397.85

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Teladoc Health has a beta of 2.14, meaning that its stock price is 114% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

Teladoc Health currently has a consensus price target of $7.43, indicating a potential upside of 5.21%. SBC Medical Group has a consensus price target of $8.50, indicating a potential upside of 177.78%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Teladoc Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
1 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.24
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

SBC Medical Group has a net margin of 24.09% compared to Teladoc Health's net margin of -6.81%. SBC Medical Group's return on equity of 15.90% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-6.81% -11.45% -5.54%
SBC Medical Group 24.09%15.90%11.61%

Summary

SBC Medical Group beats Teladoc Health on 11 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to The Pennant Group?

SBC Medical Group (NASDAQ:SBC) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

SBC Medical Group has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market.

SBC Medical Group has higher earnings, but lower revenue than The Pennant Group. SBC Medical Group is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M1.81$50.99M$0.397.85
The Pennant Group$947.71M1.12$29.58M$0.8535.79

SBC Medical Group currently has a consensus price target of $8.50, suggesting a potential upside of 177.78%. The Pennant Group has a consensus price target of $39.00, suggesting a potential upside of 28.21%. Given SBC Medical Group's higher probable upside, analysts clearly believe SBC Medical Group is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by company insiders. Comparatively, 6.9% of The Pennant Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

SBC Medical Group has a net margin of 24.09% compared to The Pennant Group's net margin of 2.96%. SBC Medical Group's return on equity of 15.90% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group24.09% 15.90% 11.61%
The Pennant Group 2.96%10.07%4.23%

In the previous week, The Pennant Group had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 3 mentions for The Pennant Group and 1 mentions for SBC Medical Group. The Pennant Group's average media sentiment score of 0.97 beat SBC Medical Group's score of 0.93 indicating that The Pennant Group is being referred to more favorably in the news media.

Company Overall Sentiment
SBC Medical Group Positive
The Pennant Group Positive

Summary

The Pennant Group beats SBC Medical Group on 9 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to CareDx?

CareDx (NASDAQ:CDNA) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

CareDx has a beta of 2.49, meaning that its stock price is 149% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

SBC Medical Group has a net margin of 24.09% compared to CareDx's net margin of -2.01%. SBC Medical Group's return on equity of 15.90% beat CareDx's return on equity.

Company Net Margins Return on Equity Return on Assets
CareDx-2.01% -2.65% -1.96%
SBC Medical Group 24.09%15.90%11.61%

In the previous week, CareDx had 1 more articles in the media than SBC Medical Group. MarketBeat recorded 2 mentions for CareDx and 1 mentions for SBC Medical Group. CareDx's average media sentiment score of 1.05 beat SBC Medical Group's score of 0.93 indicating that CareDx is being referred to more favorably in the media.

Company Overall Sentiment
CareDx Positive
SBC Medical Group Positive

SBC Medical Group has lower revenue, but higher earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareDx$379.80M3.00-$21.35M-$0.16N/A
SBC Medical Group$173.61M1.81$50.99M$0.397.85

CareDx presently has a consensus price target of $25.00, indicating a potential upside of 13.16%. SBC Medical Group has a consensus price target of $8.50, indicating a potential upside of 177.78%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe SBC Medical Group is more favorable than CareDx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareDx
1 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

60.8% of SBC Medical Group shares are owned by institutional investors. 2.4% of CareDx shares are owned by company insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

SBC Medical Group beats CareDx on 11 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to Omada Health?

Omada Health (NASDAQ:OMDA) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

SBC Medical Group has a net margin of 24.09% compared to Omada Health's net margin of -2.22%. SBC Medical Group's return on equity of 15.90% beat Omada Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Omada Health-2.22% -1.82% -1.36%
SBC Medical Group 24.09%15.90%11.61%

In the previous week, Omada Health had 3 more articles in the media than SBC Medical Group. MarketBeat recorded 4 mentions for Omada Health and 1 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 0.93 beat Omada Health's score of 0.84 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company Overall Sentiment
Omada Health Positive
SBC Medical Group Positive

Omada Health presently has a consensus target price of $22.91, suggesting a potential upside of 31.93%. SBC Medical Group has a consensus target price of $8.50, suggesting a potential upside of 177.78%. Given SBC Medical Group's higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Omada Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omada Health
1 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.69
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

60.8% of SBC Medical Group shares are held by institutional investors. 6.4% of Omada Health shares are held by company insiders. Comparatively, 81.7% of SBC Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

SBC Medical Group has lower revenue, but higher earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omada Health$283.30M3.64-$12.78M-$0.27N/A
SBC Medical Group$173.61M1.81$50.99M$0.397.85

Summary

SBC Medical Group beats Omada Health on 10 of the 15 factors compared between the two stocks.

Get SBC Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBC vs. The Competition

MetricSBC Medical GroupMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$312.56M$8.53B$6.26B$12.45B
Dividend YieldN/A1.77%2.69%5.29%
P/E Ratio7.8122.2522.4224.19
Price / Sales1.8125.50548.01125.89
Price / Cash6.1490.0542.3157.88
Price / Book1.195.059.826.71
Net Income$50.99M$178.24M$3.56B$337.09M
7 Day Performance-1.29%-1.43%-1.33%0.56%
1 Month Performance-7.55%3.26%3.64%5.10%
1 Year Performance-36.78%1.92%27.26%34.28%

SBC Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBC
SBC Medical Group
4.3446 of 5 stars
$3.06
-4.4%
$8.50
+177.8%
-31.6%$312.56M$173.61M7.81N/A
FTRE
Fortrea
3.7899 of 5 stars
$13.22
flat
$17.25
+30.5%
+271.9%$1.25B$2.71BN/A14,300
TDOC
Teladoc Health
2.393 of 5 stars
$6.63
+0.9%
$7.43
+12.1%
+9.8%$1.19B$2.51BN/A5,600
PNTG
The Pennant Group
4.6073 of 5 stars
$33.92
flat
$39.00
+15.0%
+7.0%$1.18B$1.02B39.919,700
CDNA
CareDx
2.1809 of 5 stars
$21.54
-0.4%
$25.00
+16.1%
+29.2%$1.12B$412.82MN/A740

Related Companies and Tools


This page (NASDAQ:SBC) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners